HIV vaccine SeV-G-NP

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHIV vaccine SeV-G-NP

Drug Alias NameSeV-G-NP vaccineSeV-Gag vaccine (DNAVEC/IAVI/SiBiono)SeV-G(NP)SeV-G

ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulantsCD8-positive T-Lymphocytes stimulants

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRwandaUnited KingdomKenya

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesId Pharma International Aids Vaccine Initiative

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesId Pharma International Aids Vaccine Initiative Shenzhen SiBiono GeneTech Co Ltd

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A